-

Cook Medical TriForce® Peripheral Crossing Set Now Available

original Cook Medical's TriForce® Peripheral Crossing Set (Photo: Business Wire)

Cook Medical's TriForce® Peripheral Crossing Set (Photo: Business Wire)

BLOOMINGTON, Ind.--(BUSINESS WIRE)--Cook Medical’s TriForce® Peripheral Crossing Set is now commercially available. As of January 2020, these products are available to physicians in the United States to support procedures to treat patients with vascular obstructions.

The TriForce Peripheral Crossing Set is designed to be percutaneously introduced into blood vessels and support a wire guide while performing a peripheral intervention. This device is also intended for injection of radiopaque contrast media for the purpose of angiography. TriForce is offered in two lengths and four configurations, which means physicians have several product options to treat blocked or restricted vessels in a variety of locations in the body.

Mark Breedlove, vice president of Cook Medical’s Vascular division, said, “We are excited to have this tool available for our physicians to treat complex peripheral vascular disease.”

To learn more about TriForce products, see the product page here.

About Cook Medical

Since 1963, Cook Medical has worked closely with physicians to develop technologies that eliminate the need for open surgery. Today we are combining medical devices, biologic materials and cellular therapies to help the world's healthcare systems deliver better outcomes more efficiently. We have always remained family owned so that we have the freedom to focus on what we care about: our patients, our employees, and our communities. Find out more at CookMedical.com, and for the latest news, follow us on Twitter, Facebook and LinkedIn.

Contacts

Hannah Chudleigh
External Corporate Communications, Cook Medical
812.345.5943
hannah.chudleigh@cookmedical.com

Industry:

Cook Medical

Release Summary
Cook Medical’s TriForce® Peripheral Crossing Set is now commercially available.
Release Versions
English

Contacts

Hannah Chudleigh
External Corporate Communications, Cook Medical
812.345.5943
hannah.chudleigh@cookmedical.com

More News From Cook Medical

Cook Medical Reproductive Health Business to be Acquired by CooperCompanies

BLOOMINGTON, Ind.--(BUSINESS WIRE)--Cook Medical today announced it signed a letter of intent with CooperCompanies to sell the entirety of Cook’s Reproductive Health business within the MedSurg division. CooperCompanies (NYSE:COO), a publicly held healthcare company, is focused on women’s health and fertility solutions, providing innovative products and services for every step in the ART journey. Under the proposed transaction, CooperCompanies will pay $875 million comprised of $675 million at...

Cook Medical Issues Voluntary Recall of Transseptal Needle and Transseptal Needle With Catheter

BLOOMINGTON, Ind.--(BUSINESS WIRE)--On October 8, 2021, Cook Medical issued a global, voluntary recall of the Transseptal Needle and the Transseptal Needle with Catheter....

MED Institute Receives Accreditation through the FDA Accreditation Scheme for Conformity Assessment (ASCA) Pilot Program

WEST LAFAYETTE, Ind.--(BUSINESS WIRE)--MED Institute received FDA Accreditation Scheme for Conformity Assessment (ASCA) to enhance confidence in medical device testing....
Back to Newsroom